Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Sachse, C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Smith, G; Sachse, C
      A role for CYP2D6 in nicotine metabolism? Target article on nicotine-addiction

      PSYCOLOQUY
    2. Swanson, HL; Sachse-Lee, C
      A subgroup analysis of working memory in children with reading disabilities: Domain-general or domain-specific deficiency?

      JOURNAL OF LEARNING DISABILITIES
    3. Swanson, HL; Sachse-Lee, C
      Mathematical problem solving and working memory in children with learning disabilities: Both executive and phonological processes are important

      JOURNAL OF EXPERIMENTAL CHILD PSYCHOLOGY
    4. Boorboor, P; Drescher, BE; Hartung, K; Sachse, C; Tsao, BP; Schneider, PM; Kalden, JR; Lakomek, HJ; Peter, HH; Schmidt, RE; Witte, T
      Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German Caucasians

      JOURNAL OF RHEUMATOLOGY
    5. Witte, T; Matthias, T; Arnett, FC; Peter, HH; Hartung, K; Sachse, C; Wigand, R; Braner, A; Kalden, JR; Lakomek, HJ; Schmidt, RE
      IgA and IgG autoantibodies against alpha-fodrin as markers for Sjogren's syndrome

      JOURNAL OF RHEUMATOLOGY
    6. Dettling, M; Sachse, C; Muller-Oerlinghausen, B; Roots, I; Brockmoller, J; Rolfs, A; Cascorbi, I
      Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: No association with myeloperoxidase and cytochrome P450206

      PHARMACOPSYCHIATRY
    7. Witte, T; Hartung, K; Sachse, C; Matthias, T; Fricke, M; Kalden, JR; Lakomek, HJ; Peter, HH; Schmidt, RE
      Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters

      RHEUMATOLOGY INTERNATIONAL
    8. Swanson, HL; Sachse-Lee, C
      A meta-analysis of single-subject-design intervention research for students with LD

      JOURNAL OF LEARNING DISABILITIES
    9. Sachse, C; Wolterink, G; Pallua, N
      Neutrophil intracellular pH and phagocytosis after thermal trauma

      CLINICA CHIMICA ACTA
    10. Machens, HG; Morgan, JR; Sachse, C; Berger, AC; Mailander, P
      Gene-therapy possibilities in plastic surgery

      CHIRURG
    11. Dettling, M; Sachse, C; Brockmoller, J; Schley, J; Muller-Oerlinghausen, B; Pickersgill, I; Rolfs, A; Schaub, RT; Schmider, J
      Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients

      PSYCHOPHARMACOLOGY
    12. Sachse, C; Prigge, M; Cramer, G; Pallua, N; Henkel, E
      Association between reduced human leukocyte antigen (HLA)-DR expression onblood monocytes and increased plasma level of interleukin-10 in patients with severe burns

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    13. Kerb, R; Brockmoller, J; Sachse, C; Roots, I
      Detection of the GSTM1*0 allele by long polymerase chain reaction

      PHARMACOGENETICS
    14. Aitchison, KJ; Munro, J; Wright, P; Smith, S; Makoff, AJ; Sachse, C; Sham, PC; Murray, RM; Collier, DA; Kerwin, RW
      Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    15. Aynacioglu, AS; Brockmoller, J; Bauer, S; Sachse, C; Guzelbey, P; Ongen, Z; Nacak, M; Roots, I
      Frequency of cytochrome P450CYP2C9 variants in a Turkish population and functional relevance for phenytoin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    16. Sachse, C; Brochmoller, J; Bauer, S; Roots, I
      Functional significance of a C -> A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    17. Sachse, C; Machens, HG; Felmerer, G; Berger, A; Henkel, E
      Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury

      JOURNAL OF BURN CARE & REHABILITATION
    18. Witte, T; Hartung, K; Sachse, C; Fricke, M; Buyny, S; Deicher, H; Kalden, JR; Lakomek, HJ; Peter, HH; Schmidt, RE
      Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters

      RHEUMATOLOGY INTERNATIONAL
    19. Sachse, C; Ruschen, S; Dettling, M; Schley, J; Bauer, S; Muller-Oerlinghausen, B; Roots, I; Brockmoller, J
      Flavin monooxygenase 3 (FMO3) polymorphism in a white population: Allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Aynacioglu, AS; Sachse, C; Bozkurt, A; Kortunay, S; Nacak, M; Schroder, T; Kayaalp, SO; Roots, I; Brockmoller, J
      Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6in the Turkish population

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    21. Sachse, C; Dressler, F; Henkel, E
      Usefulness of procalcitonin in neonates at risk for infection - Respond

      CLINICAL CHEMISTRY
    22. SACHSE C; BROCKMOLLER J; HILDEBRAND M; MULLER K; ROOTS I
      CORRECTNESS ELF PREDICTION OF THE CYP2D6 PHENOTYPE CONFIRMED BY GENOTYPING 47 INTERMEDIATE AND POOR METABOLIZERS OF DEBRISOQUINE

      Pharmacogenetics
    23. Brockmoller, J; Cascorbi, I; Kerb, R; Sachse, C; Roots, I
      Polymorphisms in xenobiotic conjugation and disease predisposition

      TOXICOLOGY LETTERS
    24. WITTE T; HARTUNG K; SACHSE C; MATTHIAS T; FRICKE M; DEICHER H; KALDEN JR; LAKOMEK HJ; PETER HH; SCHMIDT RE
      IGM ANTI-DSDNA ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - NEGATIVE ASSOCIATION WITH NEPHRITIS

      Rheumatology international
    25. WITTE T; HARTUNG K; MATTHIAS T; SACHSE C; FRICKE M; DEICHER H; KALDEN JR; LAKOMEK HJ; PETER HH; SCHMIDT RE
      ASSOCIATION OF IGA ANTI-DSDNA ANTIBODIES WITH VASCULITIS AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      Rheumatology international
    26. Sachse, C; Jahns-Streubel, G; Henkel, E
      First clinical evaluation of the CELL-DYN (R) 3200 haematology analyser

      CLINICAL AND LABORATORY HAEMATOLOGY
    27. SCHMIDER J; WALTER S; SACHSE C; BAUER S; MULLEROERLINGHAUSEN B; ROOTS I; BROCKMOLLER J
      METABOLISM OF ANTIPSYCHOTICS AND CYP2D6 GENOTYPE

      Naunyn-Schmiedeberg's archives of pharmacology
    28. BROCKMOLLER J; SCHMIDER J; SACHSE C; FILLER D; MULLEROERLINGHAUSEN B; ROOTS I
      THE CYP2D6 POLYMORPHISM PARTIALLY EXPLAINS THE HIGH VARIABILITY OF THE SERUM CONCENTRATIONS OF PERAZINE

      Naunyn-Schmiedeberg's archives of pharmacology
    29. SCHMIDER J; SACHSE C; WALTER S; FILLER D; KAISER R; ROOTS I; BROCKMOLLER J
      METABOLIC GENOTYPE OF SCHIZOPHRENIC-PATIENTS AND HALOPERIDOL METABOLISM

      Naunyn-Schmiedeberg's archives of pharmacology
    30. BROCKMOLLER J; SCHMIDER J; SACHSE C; SCHLEY J; MULLEROERLINGHAUSEN B; ROOTS I
      CYTOCHROME-P450 2D6 GENOTYPE PARTIALLY EXPLAINS INTERINDIVIDUAL PHARMACOKINETIC VARIABILITY OF PERAZINE AND DESMETHYLPERAZINE

      Naunyn-Schmiedeberg's archives of pharmacology
    31. MILOS PM; MCELROY SM; SACHSE C; LIRA ME; BROCKMOLLER J; ROOTS I; NELMS LF; SHAH AK; FRIEDMAN DL; SILBER BM
      CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYTOCHROME-P450 2D6

      Clinical pharmacology and therapeutics
    32. SCHMIDER J; SACHSE C; WALTER S; FILLER D; KAISER R; ROOTS I; BROCKMOLLER J
      CYP2D6 GENOTYPE IN PSYCHIATRIC-PATIENTS - IMPACT ON HALOPERIDOL METABOLISM

      Clinical pharmacology and therapeutics
    33. CASCORBI I; ACKERMANN E; SACHSE C; BROCKMOLLER J; ROOTS I
      A NOVEL CYP2CP INTRON 2T C TRANSITION AND LINKAGE TO MUTATIONS LEU(359) AND CYS(144)/

      Clinical pharmacology and therapeutics
    34. SACHSE C; DRESSLER F; HENKEL E
      INCREASED SERUM PROCALCITONIN IN NEWBORN-INFANTS WITHOUT INFECTION

      Clinical chemistry
    35. SACHSE C; JAHNSSTREUBEL G; HENKEL E
      EVALUATION ANALYZER OF THE CELL-DYN(R)-3200 HEMATOLOGY

      British Journal of Haematology
    36. WITTE T; HARTUNG K; MATTHIAS T; SACHSE C; FRICKE M; DEICHER H; KALDEN JR; LAKOMEK HJ; PETER HH; SCHMIDT RE
      IGA AND IGM ANTI-DSDNA ANTIBODIES IN SLE - ASSOCIATIONS WITH CLINICALAND LABORATORY PARAMETERS

      Arthritis and rheumatism
    37. SACHSE C; BROCKMOLLER J; BAUER S; ROOTS I
      CYTOCHROME-P450 2D6 VARIANTS IN A CAUCASIAN POPULATION - ALLELE FREQUENCIES AND PHENOTYPIC CONSEQUENCES

      American journal of human genetics
    38. SACHSE C; BROCKMOLLER J; BAUER S; REUM T; ROOTS I
      A RARE INSERTION OF T-226 IN EXON-1 OF CYP2D6 CAUSES A FRAMESHIFT ANDIS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE - CYP2D6-ASTERISK-15

      Pharmacogenetics
    39. SACHSE C; HENKEL E
      AN EVALUATION OF THE CELL-DYN 1700(R) HEMATOLOGY ANALYZER - AUTOMATEDCELL COUNTING AND 3-PART LEUKOCYTE DIFFERENTIATION

      Clinical and laboratory haematology
    40. SACHSE C; LUTHKE K; HARTUNG K; FRICKE M; LIEDVOGEL B; KALDEN JR; PETER HH; LAKOMEK HJ; HENKEL E; DEICHER H; CORVETTA A; KRAPF F; LANG B; PIRNER K; ROTHER E; SPECKER C; STANNATKIESSLING S
      SIGNIFICANCE OF ANTIBODIES TO CARDIOLIPIN IN UNSELECTED PATIENTS WITHSYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND LABORATORY ASSOCIATIONS

      Rheumatology international
    41. SACHSE C
      STREAMLINING AND INDUSTRIAL WORK - LABOR-MARKET, MANAGEMENT, LABOR ATSIEMENS IN BERLIN 1900-1939 - GERMAN - HOMBURG,H

      International review of social history


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:38:23